fbpx
  • Call Now!
  • +39 0521 986049

Our Latest

NEWS

Treat varicose veins with a technology that eliminates them without cuts or scars, and with a post-surgery course that allows the patient to resume normal life in a short time. And, at the same time, to enable vascular surgeons to intervene with high precision. This is what the French company Theraclion proposes with a technology that is based on a clinical experience of over 10 years in other indications, with about 50 peer-reviewed scientific publications. What is it about? Ultrasound therapy with SONOVEIN, which uses high-intensity focused ultrasound (HIFU), detailed high-definition ultrasound images and advanced data processing. Unlike conventional surgery, laser ablation or radiofrequency, ultrasound therapy is a completely non-invasive procedure that leaves no scars, usually requires only one session and the patient can resume daily activities immediately afterwards.

At the end of the past year, one of the 5 machines existing in the world today arrived in Italy directly from Wong Wah Hospital in Hong Kong and promises to revolutionize the treatment of chronic venous disease for which 5 million operations are performed every year.
This is Sonovein®, the first HIFU (High Intensity Focussed Ultrasound) robotic treatment, i.e. high-intensity focused ultrasound, developed by Theraclion, a Chinese company specializing in the production of high-precision surgical robots.

Ippocrate S.r.l.

Vascular surgery, phlebology, general surgery, plastic and aesthetic surgery, aesthetic medicine and dermatology, physiatrics and rehabilitation, diet and wellness.